These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15045127)

  • 1. Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones.
    Zirlik A; Leugers A; Lohrmann J; Ernst S; Sobel BE; Bode C; Nordt TK
    Thromb Haemost; 2004 Apr; 91(4):674-82. PubMed ID: 15045127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro.
    He G; Pedersen SB; Bruun JM; Lihn AS; Richelsen B
    Horm Metab Res; 2003 Jan; 35(1):18-23. PubMed ID: 12669266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes.
    Harte AL; McTernan PG; McTernan CL; Smith SA; Barnett AH; Kumar S
    Diabetes Obes Metab; 2003 Sep; 5(5):302-10. PubMed ID: 12940867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
    Hoo RL; Chow WS; Yau MH; Xu A; Tso AW; Tse HF; Fong CH; Tam S; Chan L; Lam KS
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2777-82. PubMed ID: 17932317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on PAI-1 gene expression and adipocyte differentiation.
    Ozel Demiralp D; Aktas H; Akar N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):438-46. PubMed ID: 18160587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARγ activation induces acute PAI-1 gene expression in the liver but not in adipose tissues of diabetic model mice.
    Oishi K; Tomita T; Itoh N; Ohkura N
    Thromb Res; 2011 Nov; 128(5):e81-5. PubMed ID: 21757225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells.
    Nordt TK; Peter K; Bode C; Sobel BE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1563-8. PubMed ID: 10770198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
    J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E; Takamura T; Shimizu A; Nagai Y
    J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone reduces plasminogen activator inhibitor-1 expression and secretion in cultured human adipocytes.
    Gottschling-Zeller H; Röhrig K; Hauner H
    Diabetologia; 2000 Mar; 43(3):377-83. PubMed ID: 10768100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
    Ma LJ; Marcantoni C; Linton MF; Fazio S; Fogo AB
    Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
    Skurk T; Birgel M; Lee YM; Hauner H
    Metabolism; 2006 Mar; 55(3):309-16. PubMed ID: 16483873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X; Li C; Li X; Cai L
    Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization.
    Saraf N; Sharma PK; Mondal SC; Garg VK; Singh AK
    J Pharm Pharmacol; 2012 Feb; 64(2):161-71. PubMed ID: 22221092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes.
    Zirlik A; Ernst S; Leugers A; Willecke F; Sobel BE; Bode C; Nordt TK
    Thromb Haemost; 2009 Jun; 101(6):1060-9. PubMed ID: 19492148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-gamma activation in +db/+m and +db/+db mice.
    Seto SW; Lam TY; Leung GP; Au AL; Ngai SM; Chan SW; Kwan YW
    Eur J Pharmacol; 2007 Oct; 572(1):40-8. PubMed ID: 17603034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent effects of peroxisome proliferator-activated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expression.
    Yue L; Rasouli N; Ranganathan G; Kern PA; Mazzone T
    J Biol Chem; 2004 Nov; 279(46):47626-32. PubMed ID: 15339912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells.
    Yuan X; Liu N
    J Genet Genomics; 2011 May; 38(5):193-200. PubMed ID: 21621740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
    Skurk T; Hauner H
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.